Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)
Article in Expert Opinion on Drug Safety (February 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Expert Opinion on Drug Safety (February 2024)
Article in Medicina (July 2023)
Article in Journal of Clinical Medicine (July 2023)